These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2774 related items for PubMed ID: 33849629

  • 21. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M, Vandelli P, Mighali P, Vicini R, Coluccio V, D'Amico R, COVID-19 HD Study Group.
    Trials; 2020 Jun 26; 21(1):574. PubMed ID: 32586394
    [Abstract] [Full Text] [Related]

  • 22. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ, Mundaca H, Ugarte-Gil C, Leon P, Malaga G, Chaccour C, Carcamo CP.
    Trials; 2021 Apr 09; 22(1):262. PubMed ID: 33836826
    [Abstract] [Full Text] [Related]

  • 23. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R, García-Otero L, Pons-Duran C, Marbán-Castro E, Goncé A, Llurba E, Gil MDM, Rodríguez-Zambrano MÁ, Chen H, Ramírez M, Bardají A, Menendez C.
    Trials; 2020 Jul 02; 21(1):607. PubMed ID: 32616063
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ, Hietasalo P, Koivisto AL, Kääriäinen S, Turunen J, Virtala M, Vuorinen J, Scheinin M.
    Trials; 2021 Jan 11; 22(1):44. PubMed ID: 33430933
    [Abstract] [Full Text] [Related]

  • 26. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP, Pinero JC, Zheng Y, Palma NA, Wingertzahn M.
    Trials; 2021 Apr 02; 22(1):245. PubMed ID: 33810796
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A, Krapp F, Vargas A, Cabrejos L, Argumanis E, García PL, Altamirano K, Montes M, Chacón-Uscamaita PR, García PJ.
    Trials; 2021 May 17; 22(1):342. PubMed ID: 34001174
    [Abstract] [Full Text] [Related]

  • 30. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR, Schaltz-Buchholzer F, Benfield T, Bjerregaard-Andersen M, Dalgaard LS, Dam C, Ditlev SB, Faizi G, Johansen IS, Kofoed PE, Kristensen GS, Loekkegaard ECL, Mogensen CB, Mohamed L, Ostenfeld A, Oedegaard ES, Soerensen MK, Wejse C, Jensen AKG, Nielsen S, Krause TG, Netea MG, Aaby P, Benn CS.
    Trials; 2020 Sep 17; 21(1):799. PubMed ID: 32943115
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK, Bandyopadhyay A, Singh BC, Moirangthem B, Chikara G, Saha S, Bahurupi YA.
    Trials; 2020 Oct 20; 21(1):866. PubMed ID: 33081849
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A, Anders S, de Allegri M, Nguyen HT, Souares A, McMahon S, Boerner K, Meurer M, Herbst K, Sand M, Koeppel L, Siems T, Brugnara L, Brenner S, Burk R, Lou D, Kirrmaier D, Duan Y, Ovchinnikova S, Marx M, Kräusslich HG, Knop M, Bärnighausen T, Denkinger C.
    Trials; 2021 Jan 08; 22(1):39. PubMed ID: 33419461
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM, Hydroxychloroquine COVID-19 PEP Study Team.
    Trials; 2020 Jun 03; 21(1):475. PubMed ID: 32493478
    [Abstract] [Full Text] [Related]

  • 35. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D, COVERAGE study group.
    Trials; 2020 Oct 13; 21(1):846. PubMed ID: 33050924
    [Abstract] [Full Text] [Related]

  • 36. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A, Clark H, Madsen J, Mogg R, Matthews L, Berry L, de la Serna JB, Batchelor J, Brealey D, Hussell T, Porter J, Djukanovic R, Feelisch M, Postle A, Grocott MPW.
    Trials; 2020 Dec 10; 21(1):1014. PubMed ID: 33302976
    [Abstract] [Full Text] [Related]

  • 37. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K, Pace A, Ortiz S, Kazani S, Rottinghaus S.
    Trials; 2020 Jul 13; 21(1):639. PubMed ID: 32660611
    [Abstract] [Full Text] [Related]

  • 38. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E, Castiello L, Bracci L, Urbani F, Lombardo F, Bacigalupo I, Ancidoni A, Vanacore N, Falcione A, Reggiani C, Dutti GM, Maglie MG, Papa O, Bartoletti PL, Ozzella G, Bevilacqua N, Nicastri E, Belardelli F, Sconocchia G.
    Trials; 2021 Sep 03; 22(1):584. PubMed ID: 34479601
    [Abstract] [Full Text] [Related]

  • 39. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M, Schäkel U, Djuka Fokou C, Krisam J, Stermann J, Kriegsmann K, Haberbosch I, Novotny JP, Weber S, Vehreschild M, Bornhäuser M, Bullinger L, Schmitt M, Liebregts T, Dreger P, Lorenz HM, Plaszczyca A, Bartenschlager R, Müller B, Kräusslich HG, Halama N, Jäger D, Schlenk RF, Leo A, Meuer S, Weigand MA, Motsch J, Merle U, Denkinger CM, Müller-Tidow C.
    Trials; 2020 Oct 06; 21(1):828. PubMed ID: 33023671
    [Abstract] [Full Text] [Related]

  • 40. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E, Shankar-Hari M, Hopkins P, Tunnicliffe WS, Perkins GD, Silversides J, McGuigan P, Jackson C, Boyle R, McFerran J, McDowell C, Campbell C, McFarland M, Smythe J, Thompson J, Williams B, Curley G, Laffey JG, Clarke M, O'Kane C, McAuley DF.
    Trials; 2020 Jun 03; 21(1):462. PubMed ID: 32493473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 139.